Incidence of overt proteinuria and coronary artery disease in patients with type 2 diabetes mellitus: The role of microalbuminuria and retinopathy

Diabetes Research and Clinical Practice

Volumn 65, Issue 2, 2004, Pages 159-165

  Kim, Kyoung Soo ^a   Koh, Jung Min ^a   Song, Kee Ho ^a   Nam Gung, Il Sung ^a   Kim, Min Seon ^a   Park, Joong Yeol ^a   Lee, Ki Up ^a  

^a University of Ulsan College of Medicine   (South Korea)

Author keywords

ACE; AIIRB; angiotensin converting enzyme; angiotensin II receptor blocker; blood pressure; BMI; body mass index; BP; CAD; cardiovascular disease; coronary artery disease; CVD; Diabetes mellitus; HDL; high density lipoprotein; UAE; urinary albumin excretion

Indexed keywords

ADULT; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DIABETIC NEPHROPATHY; DIABETIC RETINOPATHY; DISEASE COURSE; FEMALE; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; PROTEINURIA; STATISTICAL SIGNIFICANCE;

AGED; CORONARY DISEASE; DIABETES MELLITUS, TYPE 2; DIABETIC ANGIOPATHIES; DIABETIC NEPHROPATHIES; DIABETIC RETINOPATHY; FEMALE; HUMANS; INCIDENCE; KOREA; MALE; MIDDLE AGED; PREVALENCE; PROTEINURIA;

EID: 3042513812     PISSN: 01688227     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diabres.2004.01.001     Document Type: Article

References (25)

1. Mogensen C.E., Christensen C.K. Predicting diabetic nephropathy in insulin-dependent patients. N. Engl. J. Med. 311:1984;89-93
2. Mogensen C.E. Microalbuminuria predicts proteinuria and early mortality in maturity-onset diabetes. N. Engl. J. Med. 310:1984;356-360
3. Mogensen C.E. Microalbuminuria as a predictor of clinical diabetic nephropathy. Kidney Int. 30:1987;673-689
4. Damsgaard E.M., Froland A., Jorgensen O.D., Mogensen C.E. Eight to nine year mortality in known non-insulin-dependent diabetics and controls. Kidney Int. 41:1992;731-735
5. Mattock M.B., Morrish N.J., Viberti G., Keen H., Fitzgerald A.P., Jackson G. Prospective study of microalbuminuria as predictor of mortality in NIDDM. Diabetes. 41:1992;736-741
6. Schmitz A., Vaeth M. Microalbuminuria: a major risk factor in non-insulin-dependent diabetes. A 10-year follow-up study of 503 patients. Diabet. Med. 5:1988;126-134
7. Deckert T., Feldt-Rasmussen B., Borch-Johnsen K., Jensen T., Kofoed-Enevoldsen A. Albuminuria reflects widespread vascular damage: the Steno hypothesis. Diabetologia. 32:1989;219-226
8. Groop L., Ekstrand A., Forsblom C., et al. Insulin resistance, hypertension and microalbuminuria in patients with type 2 (non-insulin- dependent) diabetes mellitus. Diabetologia. 36:1993;642-647
9. Standl E., Stiegler H. Microalbuminuria in a random cohort of recently diagnosed type 2 (non-insulin-dependent) diabetic patients living in the Greater Munich area. Diabetologia. 36:1993;1017-1020
10. Haffner S.M., Gonzales C., Valdez R.A., et al. Is microalbuminuria part of the prediabetic state? The Mexico City Diabetes Study. Diabetologia. 36:1993;1002-1006
11. Mykkanen L., Haffner S.M., Kuusisto J., Pyorala K., Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes. 43:1994;552-557
12. Parving H-H., Gall M.-A., Skott P., et al. Prevalence and causes of albuminuria in non-insulin-dependent diabetic patients. Kidney Int. 41:1992;758-762
13. Fioretto P., Mauer M., Brocco E., et al. Patterns of renal injury in NIDDM patients with microalbuminuria. Diabetologia. 39:1996;1569-1576
14. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III), Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP), JAMA 285 (2001) 2486-2497.
15. Nelson R.G., Bennett P.H., Beck G.J., et al. Development and progression of renal disease in Pima Indians with non-insulin-dependent diabetes mellitus. Diabetic Renal Disease Study Group. N. Engl. J. Med. 335:1996;1636-1642
16. Ravid M., Savin H., Jutrin I., Bental T., Katz B., Lishner M. Long-term stabilizing effect of angiotensin-converting enzyme inhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients. Ann. Intern. Med. 118:1993;577-581
17. Mogensen C.E. Prediction of clinical diabetic nephropathy in IDDM patients. Alternatives to microalbuminuria? Diabetes. 39:1990;761-767
18. Kim Y.I., Kim C.-H., Choi C.S., et al. Microalbuminuria is associated with the insulin resistance syndrome independent of hypertension and type 2 diabetes in the Korean population. Diabetes Res. Clin. Pract. 52:2001;145-152
19. Mykkanen L., Haffner S.M., Kuusisto J., Pyorala K., Laakso M. Microalbuminuria precedes the development of NIDDM. Diabetes. 43:1994;552-557
20. Gerstein H.C., Mann J.F., Yi Q., et al. HOPE Study Investigators Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA. 286:2001;421-426
21. Roest M., Banga J.D., Janssen W.M., et al. Excessive urinary albumin levels are associated with future cardiovascular mortality in postmenopausal women. Circulation. 103:2001;3057-3061
22. Adler A.I., Stevens R.J., Manley S.E., Bilous R.W., Cull C.A., Holman R.R. The UKPDS GROUP Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int. 63:2003;225-232
23. Lee K.U., Park J.Y., Kim S.W., et al. Prevalence and associated features of albuminuria in Koreans with NIDDM. Diabetes Care. 18:1995;793-799
24. Valmadrid C.T., Klein R., Moss S.E., Klein B.E. The risk of cardiovascular disease mortality associated with microalbuminuria and gross proteinuria in persons with older-onset diabetes mellitus. Arch. Intern. Med. 160:2000;1093-1100
25. Christensen P.K., Larsen S., Horn T., Olsen S., Parving H.H. Causes of albuminuria in patients with type 2 diabetes without diabetic retinopathy. Kidney Int. 58:2000;1719-1731